OOIR: Observatory of International Research

Papers

(The TQCC of Clinical & Translational Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Intimal macrophages develop from circulating monocytes during vasculitis	94
	76
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis	37
Early‐like differentiation status of systemic PD‐1⁺CD8⁺ T cells predicts PD‐1 blockade outcome in non‐small cell lung cancer	33
The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related disease	28
	26
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis	25
Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates	25
	23
Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide	22
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis	21
Cord blood granulocyte levels are associated with severe bronchiolitis in the first year of life	19
Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival	19
Siglec‐7 and Siglec‐9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling	18
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation	17
Diversification and shared features of tumor‐binding antibody repertoires in tumor, sentinel lymph node and blood of three patients with breast cancer	17
	16
LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza	16
	16
	15
IL‐15‐induced CD38⁺HLA‐DR⁺CD8⁺ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis	15
Characteristics of PD‐1⁺CD4⁺ T cells in peripheral blood and synovium of rheumatoid arthritis patients	15
Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinoma	14
Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease	14
Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis	12

Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection	12
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system	12
Primary SARS‐CoV‐2 infection in children and adults results in similar Fc‐mediated antibody effector function patterns	12
Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant	11
Advances in bacteria‐based drug delivery systems for anti‐tumor therapy	10
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?	10
Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8⁺ T cells	10
The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis	10
Organ‐on‐chip for advancing CAR therapy	10
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients	9
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis	9
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models	9
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection	9
Roadmap for understanding mechanisms on how Epstein–Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials	9
Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint	8
	8
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients	8
Distinct MAIT cell phenotypes associated with sepsis clinical outcome in emergency department patients	8
Anti‐signal recognition particle antibodies induce cardiac diastolic dysfunction via oxidative stress injury	8
	8
	8
	8
Improving diagnosis in patients with obstetric antiphospholipid syndrome through the evaluation of non‐criteria antibodies	7
Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia	7
	7
	7
Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery	7
From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL‐33	7
The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities	7
Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma	6
Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors	6
Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitroIC₅₀ values predict SARS‐CoV‐2 neutralising antibody titres	6
	6
Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non‐infectious uveitis	6
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation	6
Understanding the tumor microenvironment in head and neck squamous cell carcinoma	6
γδ T cells mediate robust anti‐HIV functions during antiretroviral therapy regardless of immune checkpoint expression	6
Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation	6